Open an account

Sensus Healthcare

SRTS · NASDAQ

$2.75−$0.01 (−0.36%)TodayMarket closed ·
Prev close $2.76

About SRTS

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 60 full-time employees. The company went IPO on 2016-06-03. The firm is engaged in the development and delivery of non-invasive treatments for non-melanoma skin cancer (NMSC) and post-surgical keloid scar prevention. The firm uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is incorporated into a portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT technology is used to effectively and safely treat oncological and non-oncological skin conditions. The SRT-100 is a photon x-ray low-energy SRT system that provides patients with an alternative to surgery for treating NMSC, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with an SRT-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and comprehensive dosimetry parameters.

Employees
60
Headquarters
Boca Raton, Florida
Listed
Jun 3, 2016
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
sensushealthcare.com

SRTS key statistics

Market cap
45.27M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
21.08K
Volume
50.92K
Open price
$2.77
High today
$2.89
Low today
$2.73
52 Week high
$5.49
52 Week low
$2.66

Sensus Healthcare (SRTS) at a glance

As of Oct 20, 2026, Sensus Healthcare (SRTS) shares are priced at $2.75, giving the company a market cap of 45.27M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.73 and $2.89. The current price is 0.7% above the day's low and 4.8% below its high.

Volume so far is 50.92K shares, above the average of 21.08K shares a day.

Over the past year Sensus Healthcare has ranged from $2.66 to $5.49, and now sits 3% of the way up that range.

Sensus Healthcare met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.53 per share against an estimate of -$0.1275.

The average analyst price target is $5.48, 99.4% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 6 analystsAvg $5.48
Low
$4.04
Now
$2.75
High
$6.30

SRTS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 412.2% on average.

  1. Q3 FY24: reported $0.07 per share against an estimate of -$0.0102
  2. Q4 FY24: reported $0.09 per share against an estimate of $0.1265
  3. Q1 FY25: reported -$0.16 per share against an estimate of $0.0347
  4. Q2 FY25: reported -$0.06 per share against an estimate of $0.0265
  5. Q3 FY25: reported -$0.06 per share against an estimate of -$0.0969
  6. Q4 FY25: reported -$0.19 per share against an estimate of -$0.0714
  7. Q1 FY26: reported -$0.16 per share against an estimate of -$0.1275
  8. Q2 FY26: reported -$0.53 per share against an estimate of -$0.1275

SRTS news

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Full Transcript: Sensus Healthcare Q2 2026 Earnings Call

  • Press releaseBusiness Wire

    Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights

  • Press releaseBusiness Wire

    Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseBusiness Wire

    Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

  • Press releaseBusiness Wire

    Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

Similar companies

Companies in the same industry as Sensus Healthcare

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.